Literature DB >> 11521066

The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity.

H W Harris1, J E Gosnell, Z L Kumwenda.   

Abstract

Bacterial endotoxin (LPS) elicits dramatic responses in the host including elevated plasma lipid levels due to the increased synthesis and secretion of triglyceride (TG)-rich lipoproteins by the liver, and the inhibition of lipoprotein lipase. This cytokine-induced hyperlipoproteinemia, clinically termed the "lipemia of sepsis", was customarily thought to represent the mobilization of lipid stores to fuel the host response to infection. However, since lipoproteins can also bind and neutralize LPS, we hypothesize that TG-rich lipoproteins (VLDL and chylomicrons) are also components of an innate, non-adaptive host immune response to infection. Herein we review data demonstrating the capacity of lipoproteins to bind LPS, protect against LPS-induced toxicity, and modulate the overall host response to this bacterial toxin. Lastly, we propose a pathway whereby lipoprotein-bound LPS may represent a novel, endogenous mechanism for regulating the hepatic acute phase response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11521066

Source DB:  PubMed          Journal:  J Endotoxin Res        ISSN: 0968-0519


  21 in total

1.  More than inflammation: interleukin-1beta polymorphisms and the lipid metabolism.

Authors:  Mihai G Netea; Charles A Dinarello
Journal:  J Clin Endocrinol Metab       Date:  2011-05       Impact factor: 5.958

2.  Apolipoprotein C1 in synovial fluid discriminates septic arthritis from rheumatoid arthritis but not from pseudogout.

Authors:  Margot Clapasson; Candice Trocmé; Anais Courtier; Philippe Gaudin; Olivier Epaulard; Athan Baillet
Journal:  Clin Rheumatol       Date:  2020-04-12       Impact factor: 2.980

Review 3.  Cholesterol, inflammation and innate immunity.

Authors:  Alan R Tall; Laurent Yvan-Charvet
Journal:  Nat Rev Immunol       Date:  2015-02       Impact factor: 53.106

4.  Benefit of farnesoid X receptor inhibition in obstructive cholestasis.

Authors:  Catherine Stedman; Christopher Liddle; Sally Coulter; Junichiro Sonoda; Jacqueline G Alvarez; Ronald M Evans; Michael Downes
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-14       Impact factor: 11.205

5.  Increased inflammation, impaired bacterial clearance, and metabolic disruption after gram-negative sepsis in Mkp-1-deficient mice.

Authors:  W Joshua Frazier; Xianxi Wang; Lyn M Wancket; Xiang-An Li; Xiaomei Meng; Leif D Nelin; Andrew C B Cato; Yusen Liu
Journal:  J Immunol       Date:  2009-11-04       Impact factor: 5.422

6.  Liver sinusoidal endothelial cells and acute non-oxidative hepatic injury induced by Pseudomonas aeruginosa pyocyanin.

Authors:  Rajkumar Cheluvappa; Victoria C Cogger; Sun Young Kwun; Jennifer N O'Reilly; David G Le Couteur; Sarah N Hilmer
Journal:  Int J Exp Pathol       Date:  2008-12       Impact factor: 1.925

Review 7.  Inflammation and lipid signaling in the etiology of insulin resistance.

Authors:  Christopher K Glass; Jerrold M Olefsky
Journal:  Cell Metab       Date:  2012-05-02       Impact factor: 27.287

8.  Targeted metabolomics for discrimination of systemic inflammatory disorders in critically ill patients.

Authors:  Diana Schmerler; Sophie Neugebauer; Katrin Ludewig; Sibylle Bremer-Streck; Frank Martin Brunkhorst; Michael Kiehntopf
Journal:  J Lipid Res       Date:  2012-05-11       Impact factor: 5.922

9.  Tularemia induces different biochemical responses in BALB/c mice and common voles.

Authors:  Hana Bandouchova; Jana Sedlackova; Miroslav Pohanka; Ladislav Novotny; Martin Hubalek; Frantisek Treml; Frantisek Vitula; Jiri Pikula
Journal:  BMC Infect Dis       Date:  2009-06-26       Impact factor: 3.090

Review 10.  HDL and persistent inflammation immunosuppression and catabolism syndrome.

Authors:  Grant Barker; Julia R Winer; Faheem W Guirgis; Srinivasa Reddy
Journal:  Curr Opin Lipidol       Date:  2021-10-01       Impact factor: 4.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.